Companies: 10,795·Total market cap: $144.5T
McKesson Europe AG

McKesson Europe AG

CAKFYOTCHealthcare
$4.10
+$0.00(+0.00%)
Market Cap$5.4B
P/E Ratio
52W High$4.81
52W Low$4.02

McKesson Europe AG (CAKFY) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

CAKFY · shares outstanding · updated Jun 10, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
1.016B +0.00% YoY Change
FY · as of Mar 31, 2022 · Reported in EUR
vs 1.016B in FY 2021
Diluted Shares Outstanding
1.016B
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
+0.00%
year-over-year
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-10

Shares Outstanding Growth Rate

3-Year CAGR
+0.0%
2019 → 2022
5-Year CAGR
+0.0%
2017 → 2022
10-Year CAGRincreasing
+1.8%
2011 → 2022

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2022Latest
Diluted Shares: 1.016B
1.016B
+0.00%
FY 2021
Diluted Shares: 1.016B
1.016B
+0.00%
FY 2020
Diluted Shares: 1.016B
1.016B
+0.00%
FY 2019
Diluted Shares: 1.016B
1.016B
+0.00%
FY 2018
Diluted Shares: 1.016B
1.016B
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs CAKFY
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+146.2%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+139.0%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+75.2%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+52.5%
#5
McKesson Europe AGCAKFY
McKesson Europe AGYOU
1.016B
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-10.4%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-11.6%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

McKesson Europe AG (CAKFY) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of March 31, 2022, McKesson Europe AG reports 1.016B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

McKesson Europe AG's basic shares outstanding (1.016B) represents currently issued shares. Diluted shares outstanding (1.016B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

McKesson Europe AG's float is — (— of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · EUR

About shares outstanding & methodology

McKesson Europe AG (CAKFY) shares outstanding history from 2002 to 2022. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

McKesson Europe AG shares outstanding for the fiscal year ending March 31, 2022 were 1.016B, a 0.00% increase year-over-year. McKesson Europe AG FY 2022 shares outstanding were 1.016B, a +0.00% increase from FY 2021.

McKesson Europe AG is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +1.8% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

CAKFY shares outstanding · 4 questions

As of March 31, 2022, McKesson Europe AG (CAKFY) has approximately 1.016B basic shares outstanding and 1.016B diluted shares outstanding. This represents a +0.00% year-over-year increase from FY 2021 (1.016B). The increase may reflect equity compensation issuances or secondary offerings.

CAKFY shares outstandinghow many shares does CAKFY haveCAKFY basic shares 2022CAKFY diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · McKesson Europe AG SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-10